发明名称 |
Methods of using and compositions comprising sibutramine metabolites optionally in combination with other pharmacologically active compounds |
摘要 |
Methods are disclosed for the treatment and prevention of disorders and conditions such as, but are not limited to: eating disorders; weight gain; obesity; irritable bowel syndrome; obsessive-compulsive disorders; platelet adhesion; apnea; affective disorders such as attention deficit disorders, depression, and anxiety; male and female sexual function disorders; restless leg syndrome; osteoarthritis; substance abuse including nicotine and cocaine addiction; narcolepsy; pain such as neuropathic pain, diabetic neuropathy, and chronic pain; migraines; cerebral function disorders; chronic disorders such as premenstrual syndrome; and incontinence. Pharmaceutical compositions and dosage forms are also disclosed which comprise a racemic or optically pure sibutramine metabolite and an optional additional pharmacologically active compound.
|
申请公布号 |
US2002010198(A1) |
申请公布日期 |
2002.01.24 |
申请号 |
US20010770663 |
申请日期 |
2001.01.29 |
申请人 |
JERUSSI THOMAS P.;SENANAYAKE CHRISANTHA H.;FANG QUN K. |
发明人 |
JERUSSI THOMAS P.;SENANAYAKE CHRISANTHA H.;FANG QUN K. |
分类号 |
A61K9/20;A61K31/11;A61K31/135;A61K31/137;A61K31/40;A61K31/415;A61K31/44;A61K31/475;A61K31/495;A61K31/50;A61K31/505;A61K31/52;A61K45/06;A61P15/00;A61P25/00;(IPC1-7):A61K31/135;A61K31/519 |
主分类号 |
A61K9/20 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|